Earnings results expected in 21 days
Summary
BVF closed today higher at €4.8, an increase of 2.76% from yesterday's close, completing a monthly decrease of -18.62% or €1.1. Over the past 12 months, BVF stock lost -37.8%.
BVF pays dividends to its shareholders, with the most recent payment made on Dec 22, 2010. The next estimated payment will be in 22 Dec 2010 on Dec 22, 2010 for a total of €1.
The last earnings report, released on Feb 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Apr 30, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track BVF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BVF Chart
Bausch Health Companies Inc. Dividends
 BVF 10 Nov 2010 Estimated | Other | €1 Per Share |
| BVF 10 Nov 2010 | Other | €1 Per Share |
Bausch Health Companies Inc. Earnings
| 30 Apr 2025 (21 Days) Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | - Cons. EPS | - EPS |
| 1 Aug 2024 Date | | - Cons. EPS | - EPS |
| BVF 10 Nov 2010 Estimated | Other | €1 Per Share |
| BVF 10 Nov 2010 | Other | €1 Per Share |
| 30 Apr 2025 (21 Days) Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | - Cons. EPS | - EPS |
| 1 Aug 2024 Date | | - Cons. EPS | - EPS |
Bausch Health Companies Inc. (BVF) FAQ
What is the stock price today?
The current price is €4.80.
On which exchange is it traded?
Bausch Health Companies Inc. is listed on NYSE.
What is its stock symbol?
The ticker symbol is BVF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Apr 30, 2025.
Has Bausch Health Companies Inc. ever had a stock split?
No, there has never been a stock split.
Bausch Health Companies Inc. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Thomas J. Appio CEO | XFRA Exchange | CA0717341071 ISIN |
| Canada Country | 20,270 Employees | 11 Jun 2014 Last Dividend | 16 Oct 2000 Last Split | - IPO Date |
Overview
Bausch Health Companies Inc. is a global player in the specialized pharmaceutical and medical device sector, with operations spanning both the United States and numerous other countries around the world. Its focus areas include gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. Originally known as Valeant Pharmaceuticals International, Inc., the company underwent a name change in July 2018, marking a new chapter in its history. Headquartered in Laval, Canada, the organization functions through five key segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb, each targeting specific market needs.
Products and Services
Bausch Health's diverse portfolio extends across various medical domains, including:
- Gastroenterology: Under the Salix segment, the company provides innovative products aimed at gastrointestinal health, catering primarily to the US market.
- International Pharmaceutical and Medical Devices: The International segment encompasses the distribution of branded and generic pharmaceuticals, OTC products, and aesthetic medical devices across different countries, focusing on meeting global health needs.
- Aesthetic Medical Devices: Through the Solta Medical segment, Bausch Health engages in the development and sale of cutting-edge aesthetic devices, showcasing its commitment to advancing beauty and dermatological care.
- Diversified Products: The Diversified segment offers a wide range of pharmaceuticals in neurology and various other therapeutic classes, including generic products, ortho dermatologic products, and dentistry products within the US. This diversification underscores the company's holistic approach to healthcare.
- Vision Care and Ophthalmic Products: The Bausch + Lomb segment, named after the well-known eye health brand, provides a comprehensive line of products to address vision care, surgical requirements, and ophthalmic pharmaceutical needs, underlining Bausch Health's prominence in eye health solutions.
Contact Information
Address: 2150 St. ElzEar Boulevard West
Phone: 514 744 6792
Website: https://www.bauschhealth.com
2025 © Marketlog. All Rights Reserved.
